Nuoin Biotechnology, founded in 2020, is revolutionizing the healthcare industry with its rapid and comprehensive pathogen detection solutions. The company's slogan "Empowering healthcare with rapid and comprehensive pathogen detection solutions" encapsulates its mission. NuoinBio specializes in innovative tools for infectious pathogen diagnosis, prioritizing multiplex PCR and high-throughput sequencing techniques. Their portfolio includes advanced nucleic acid extraction, host removal, PCR primer design algorithms, pathogenic microorganism database compression, and an intelligent data analysis and report interpretation system. In November 2021, the company secured a Seed Round investment from EasyDiagnosis, signifying confidence in its cutting-edge technology within the Health Care sector.
No recent news or press coverage available for Nuoin Biotechnology.